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Objective: Our aim was to analyze, for the first time, the human fetal liver proteome in
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spectroscopy.
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and/or maternal smoking) were found in 22 protein spots. Maternal smoking affected
proteins with roles in post-translational protein processing and secretion (ERP29,
PDIA3), stress responses and detoxification (HSP90AA1, HSBP1, ALDH7A1, CAT)
and homeostasis (FLT, ECHS1, GLUD1, AFP, SDHA). While proteins involved in
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cellular homeostasis, inflammation, proliferation and apoptosis were affected in males
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 3 
INTRODUCTION  55 
 56 
The liver is essential for detoxification and homeostasis by metabolizing and/or assisting in the excretion of a wide 57 
range of xenotoxicants, including alcohol, drugs, and tobacco smoke constituents. In the human the fetal liver is 58 
active and because 70% of its blood supply is directly from the fetomaternal interface, is directly exposed to 59 
potentially harmful agents from the maternal circulation. Tobacco smoke contains a mixture of ~5,000 chemicals 60 
and the human fetal liver responds to maternal smoking by up-regulating Phase I and Phase II enzyme transcripts 61 
(1). Strikingly, the human fetal liver also expresses transcripts and proteins associated with altering steroid 62 
hormone function/activity in the mother and fetus. These include CYP19A1 (2), CYP3A7 (2, 3) and SULT 63 
enzymes (2, 4). The fetal liver is the main hematopoietic organ during the second trimester in humans (5) and also 64 
secrets high levels of α-fetoprotein (AFP), sex-hormone binding globulin (SHBG) (6), IGF-1 and IGF-2 (7). It is 65 
clear, therefore, that the human fetal liver functions in the development and protection of the fetus and in the 66 
regulation of steroid hormone levels/actions during pregnancy.  67 
 68 
Maternal smoking is associated with diverse negative outcomes for the health of the neonate [including reduced 69 
birth weight, premature delivery and stillbirth (8, 9)] and predisposition of the offspring to long-term health risks 70 
[including metabolic syndrome (10, 11), reduced fertility (12, 13) and psychosomatic problems (15)]. Around 30% 71 
of women continue to smoke once pregnant (16) and it remains one of the most important modifiable risk factors 72 
during pregnancy. Maternal smoking restricts the fetal oxygen supply and increases carbon monoxide burden to the 73 
conceptus but also disrupt fetal development through other mechanisms; previous studies from this group have 74 
identified some of these mechanisms such as endocrine signaling (1, 17) but a greater understanding of how 75 
maternal smoking links to disease in the offspring is required. Given the importance of the fetal liver to human fetal 76 
development and its susceptibility to maternal smoking we have, for the first time, used a proteomics approach to 77 
identify proteins and pathways that are dysregulated in the human fetal liver by maternal smoking. 78 
79 
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MATERIALS AND METHODS 80 
 81 
Study design 82 
 83 
Our cohort of 55 human fetal liver extracts from second trimester (12-17 weeks [wk.]) elective pregnancy 84 
terminations was retrospectively divided into four groups according to sex and validated smoke exposure (reflected 85 
by threshold plasma cotinine levels) (n=14 control and 13 smoke exposed females; 15 control and 13 smoke-86 
exposed females) as described previously (1). From this 55-sample cohort, 24 (i.e. n=6 from each group) balanced 87 
by age fetal liver protein extracts were chosen for proteomics so that each group contained 1 x 12wk, 2 x 13wk, 1 x 88 
14wk, 1 x 15 wk and 1 x 16/17wk fetal liver protein extracts.  89 
 90 
Sample collection and processing 91 
 92 
Women undergoing elective medical terminations of normally-progressing pregnancies gave full written informed 93 
consent for the use of their fetal material to independent nurses at the Aberdeen Pregnancy Counselling Service as 94 
previously described (18,19). Blocks of 30 mg from the central lobe of the liver were quickly dissected, snap frozen 95 
on dry ice and stored at -80°C until further use. Protein extracts were prepared from frozen liver pieces from 30 mg 96 
blocks dissected from the outer side of the right lobe of the liver using AllpPrep kits (#80004, Qiagen, Manchester, 97 
UK) according to the manufacturer’s instructions. Total RNA was extracted using TRIzol (Life Technologies, 98 
Paisley, UK) according to the manufacturer’s guidelines as previously described (1).  99 
 100 
Proteomics 101 
 102 
Within each group, equal amounts (100 μg) of protein extracts from each fetal liver were combined. The four 103 
protein pools we treated with ReadyPrep 2-D Cleanup Kit (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) to 104 
remove salt and other contaminants according to the manufacturer’s instructions. The soluble protein fractions were 105 
separated using 2D gel electrophoresis in quadruplicate (n=4) as described previously (20) using a pH 3 – 10 106 
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immobilized pH gradient gel (GE Healthcare, Uppsala, Sweden) for the first dimension and a 10–15% gradient 107 
polyacrylamide gel for the second dimension. Proteins were detected using Colloidal Coomassie Blue G250 and 108 
scanned using an Ettan DIGE Imager (GE Healthcare) and stained gels were analyzed using Progenesis SameSpots 109 
software V6.01 (Nonlinear Dynamics, Newcastle, UK) (21). Individual spot volumes were expressed as normalized 110 
volumes relative to the total detected spot volume for each gel to minimize potential analytical artefacts from 111 
protein loading variations and migration. Progenesis SameSpots was used to combine the gel quadruplicates and 112 
calculate fold-changes and significance (by ANOVA of log-normalized values). Molecular mass and pI of spots 113 
was estimated from separate gels electrophoresed with pH and MW markers. Proteins in the gel pieces were 114 
digested with trypsin and peptides identified using LC-MS/MS as previously described [see (20) and Suppl. 115 
Materials and Methods]. Statistically significant Mascot scores and good sequence coverage were considered to be 116 
positive identifications. 117 
 118 
Real-Time PCR 119 
 120 
Real-time PCR was carried out in fetal liver cDNAs from our larger 55-sample cohort (14 control and 13 smoke 121 
exposed females; 15 control and 13 smoke-exposed females) and the same methods as described previously with 122 
values normalized against the housekeeping genes B2M, TMM1 and TBP (1,2, 22). Primers for query genes were 123 
designed using Primer Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to span exon junction and to have an 124 
annealing temperature of 65°C. Test real-time PCR runs were performed to ensure that primer pairs do not amplify 125 
genomic DNA and amplification efficiency was determined using serial dilution of human fetal liver cDNA as 126 
template. Gene primer sequences are shown in Suppl. Table S1.  127 
 128 
Western Blots  129 
 130 
Individual human fetal liver protein extracts from the same preparation used for the proteomics were separated (30 131 
μg/lane) in 26-well 4-12% Bis-Tris gradient precast gels (Invitrogen Ltd, Paisley, UK) under reducing conditions 132 
according to the manufacturer’s specifications (20). Gels were blotted on Immobilon-FL membrane (Millipore Ltd, 133 
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Watford, UK), blocked and probed with antibodies as previously described (20). Antibodies and dilutions used are 134 
detailed in Suppl. Table S2. Protein bands were visualized using Odyssey infrared fluorescent imager and images 135 
were analyzed using Phoretix 1D Advanced software (Nonlinear Dynamics Ltd, Newcastle upon Tyne, UK) as 136 
detailed in (20). Membranes were reused without stripping and were probed with more than one antibody (typically 137 
two to three antibodies) when target protein sizes were considerably different. ACTB probe served as a loading 138 
control and following the validation of the use of ACTB for this purpose in the fetal liver, the volume of each 139 
protein band in each lane was normalized against respective ACTB band volumes for the same lanes.  140 
 141 
Statistical and Ingenuity Pathway Analysis 142 
 143 
Statistical analysis was performed using the JMP statistical Software (http://www.jmp.com/software/).  For each set 144 
of normalized values a Normality test was performed followed by either One-way ANOVA (for normally-145 
distributed values) or Wilcoxon-Mann-Whitney test (for non-normally distributed values) to calculate statistically 146 
significant differences among means. Proteins exhibiting treatment-specific alterations in expression were analyzed 147 
using IPA V9.0 (Ingenuity Systems, http://www.ingenuity.com), including canonical pathway analysis, functional 148 
network analysis.   149 
150 
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RESULTS  151 
 152 
Identification of fetal liver proteins affected by maternal smoking and/or fetal sex  153 
 154 
Overall, 494 fetal liver protein spots showed reproducibility across replicates of Coomassie-stained 2D PAGE gels 155 
following analysis by Samespots software. Twenty two of these protein spots showed statistically significant spot 156 
volume differences between at least two of the four groups (male/female, smoking/non-smoking, P<0.05) and were 157 
suitable for LC-MS/MS identification (Fig. 1). For 3 of these spots, peptide fragments were unambiguously 158 
assigned to a single protein. For 14 spots, peptide fragments were identified which belonged to more than one 159 
protein and the primary protein in the spot was identified based on (i) high Mascot score, (ii) agreement between 160 
estimated (i.e. from electrophoretic gel mobility) and calculated molecular weight and isoelectric point, and (iii) 161 
peptide coverage. For 5 spots, peptide fragments could be assigned to two proteins with similar likelihood (Table 162 
1). The 25 differentially expressed proteins are involved in processes including post-translational protein 163 
processing and secretion (ERP29, PDIA3), stress responses and detoxification (HSP90AA1, HSBP1, ALDH7A1, 164 
CAT) and homeostasis (FLT, ECHS1, GLUD1, SERPINA1, AFP, SDHA) (Suppl. Table S4). Spot 1090 (CCT6A) 165 
was more abundant in control males than females and spot 1673 (ERP29) was more abundant in smoke-exposed 166 
females than smoke-exposed males. ERP29 was also very likely to be the primary protein in spots 1684 and 1678, 167 
which were affected by maternal smoking (Table 1). Detailed information of all the proteins identified, spot 168 
characteristics and protein functions are provided in Suppl. Tables S3 and S4). Sex-specific spot volume 169 
differences (female controls vs male controls) were identified for six spots (990, AFP; 1090, CCT6A; 1678, 170 
ERP29; 1221, ALDH7A1; 1501, CRYL1; 1006, SDHA: Table 1). Maternal smoking induced sex differences in 171 
spot volumes for 14 spots and reversed sex-differences in 3 spot volumes (Table 1). Accounting for the potential 172 
presence of more than one protein in a spot, spot volumes were altered in 24 identified proteins among the four 173 
groups overall.  174 
 175 
Validation of proteomic hits by transcript and/or protein measurements  176 
 177 
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Transcript and/or protein levels of the identified proteins were quantified in individual samples in all groups using 178 
real-time PCR and 1D-Western blot respectively (Fig. 2-3; Suppl. Fig. S1-2). There was a modest degree of 179 
agreement between proteomic predictions and transcript levels, both with regard to the effect of smoking and/or sex 180 
differences. FLT and ALDH7A1 mirrored mean spot volume differences (spots 1786 and 1221 respectively) (Fig. 181 
2A-B). In contrast, while there were differences in PNP and HSP901AA1 transcript levels among the four groups, 182 
these did not closely mirror protein spot volume differences (Fig. 2C-D). Similarly, ECHS1, GLUD1, SPRYD4, 183 
USP5, PGK1, CRYL1 and ERP29 transcript levels transcript levels poorly correlated with spot volume differences 184 
(Suppl. Fig. S1). PDIA3, AFP, CALR, SERPINA1, HSPB1 and YWHAE protein levels measured by Western blot 185 
related poorly to spot volume differences with only CAT protein levels consistent with proteomics data (Fig. 3; 186 
Suppl. Fig S2). 187 
 188 
To investigate the apparent discrepancy between Western blot protein quantitation and proteomic 2D PAGE data, 189 
2D-Western blots using the fetal liver protein pools employed for the proteomics were probed with the same 190 
antibodies employed for 1D-Western blots. The resulting blots were superimposed on the Coomassie-stained gel 191 
images to identify which antibody-stained spots showed volume differences by Samespots analysis. For AFP, 192 
PDIA3, HSPB1 and CAT the single band observed in 1D Western blots resolved to two or more spots of similar 193 
molecular weight but different pI, only one of which was found to have a statistically significant volume difference 194 
among groups (Fig. 3). This demonstrated that total protein level quantification (as in conventional 1D-Western 195 
blots) will not always match proteomic predictions and provided an explanation for the discrepancy between 1D-196 
Western blot protein levels and spot volumes measurements. Antibodies against SERPINA1, CALR and YWHAE 197 
identified two bands of close molecular weight for each protein in 1D-Western blots. Protein bands for SERPINA1, 198 
CALR and YWHAE, resolved to a single spot in 2D-Western blots and indicated that quantification of 1D-Western 199 
blot bands should mirror spot volume measurements (Suppl. Fig. S2); since that was not the case, SERPINA1, 200 
CALR and YWHAE proteins were considered as false positives. 201 
 202 
Sex-specific liver proteome alterations by maternal smoking  203 
 204 
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From the fetal liver proteins affected by maternal smoking, only ECHS1, ALDH7A1, TPI1, KRT8 and ERP29 205 
were affected in both sexes. AFP, PGK1, KRT8, GLUD1, CAT, CRYL1, USP5, HSP90AA1, CAT, SDHA were 206 
primarily affected in females while SPRYD4, FLT1, PNP, PDIA3, HSPB1 and EEF1B2 were primarily affected in 207 
males (Table 1). The fetal liver proteins affected by maternal smoking in either sex were functionally analyzed and 208 
related to physiological and disease pathways using IPA software (Table 2). The majority of proteins belonging to 209 
pathways relating to cancers, cancer-development and necrosis were dysregulated in both sexes. Inflammation, 210 
cellular homeostasis, proliferation and apoptotic pathways were preferentially dysregulated in males and glucose 211 
metabolism disorder pathway was preferentially dysregulated in females (Table 2). Protein levels of the mitotic 212 
marker phospho-serine10 histone H3 were measured in protein extracts and the absence of any statistically 213 
significant differences indicates that proliferation was not affected by fetal sex or maternal smoking (Suppl. Fig 214 
S3).  215 
216 
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DISCUSSION 217 
 218 
We took a global approach not previously used for the human fetal liver and compared the proteomes of male and 219 
female control and smoke-exposed second trimester fetuses. This led to the identification of proteins primarily 220 
involved in stress responses, homeostasis, metabolism, post-translational protein processing and secretion, 221 
paralleling the known effects of cigarette smoking in adults (23, 24, 25). Even though maternal smoking modestly 222 
altered the levels of affected proteins (alterations ranged from 15-40% compared to Controls, Table 1), small 223 
changes in the levels of multiple proteins and/or protein post-translational modifications can lead to significant 224 
phenotypic alterations in organ function (26). Given that the affected proteins are involved in both pathological and 225 
physiological processes, smoking-induced alterations in their levels in the fetal liver may be linked to potentially 226 
adverse health outcomes for the offspring. In some instances, in utero smoke exposure has been associated with 227 
differential health outcomes in prepubertal boys and girls; boys are at a higher risk of conduct disorder (15) while 228 
girls are more prone to drug dependence and increased body weight (15, 27). The differential responses between 229 
male and female fetal livers described here suggests that sex-specific health outcomes might be related to important 230 
differential in utero molecular responses, indicating that sex differences in fetal liver responses to maternal 231 
smoking may contribute to subsequent disease predisposition.   232 
 233 
The approach used in this study relied on the 2D separation of proteomes by size and pI, which allowed us to 234 
simultaneously compare protein levels in the observable proteomes among the four groups. Subsequent LC-MS/MS 235 
was used to identify the proteins whose volumes showed significant changes and 2D-WBs were used to provide 236 
information about the putative post-translational modification(s) of the identified proteins. In contrast to the 237 
conventional, hypothesis-driven 1D WBs, our approach aimed to provide a top-down view of the proteomes 238 
examined. However, the liver proteome contains over 6,800 individual proteins (28) and the 494 good quality 239 
Coomassie-stained spots included in our analysis inevitably represent the most abundant proteins, which is a 240 
significant disadvantage compared to conventional 1D-WB approaches. Proteins can resolve to multiple spots of 241 
different MW and/or pI depending on isoform expression and/or post-translational modifications and obtaining 24 242 
different proteins (Table 1) from 22 differentially expressed protein spots is by no means surprising. 2D gel 243 
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separation-based proteomic approaches as described here can identify volume differences in a single spot that 244 
may not correspond to the total protein levels but rather specific forms/isoforms of a given protein. This is the most 245 
likely explanation for most cases where poor correlations between transcript/protein levels and spot volumes were 246 
observed. Group differences in individual fetal PDIA3, AFP and HSBP1 total protein levels (quantified using 1D-247 
Western blots) were likely not matched to proteomic spot volume differences because significant volume changes 248 
occurring in a single spot containing a given protein, as opposed to total spot volume of all spots containing that 249 
protein will not necessarily reflect total protein levels (Fig. 3). In the case of SERPINA1, CALR and YWHAE, a 250 
single band by 1D-Western blot reflected a single spot in 2D-Western blots (Suppl. Fig. S2). Therefore, a lack of 251 
correlation between spot volume differences and protein level quantification strongly implies that SERPINA1, 252 
CALR and YWHAE were either false positives or the spot volume differences reflected the presence of other 253 
unresolved proteins in our proteomic analysis.  254 
 255 
Endoplasmic reticulum changes induced by maternal smoking  256 
 257 
Changes in PDIA3, AFP, HSBP1 and CAT proteins suggest that maternal smoking has subtle effects on the fetal 258 
liver proteome. Single bands on 1D-Western blot for these proteins resolved as two or more bands on 2D gels, 259 
indicating alterations in protein conjugation or phosphorylation. The chaperone protein PDIA3 has disulfide 260 
isomerase activity and is involved in the folding of endoplasmic reticulum proteins. PDIA3 is frequently 261 
encountered in proteomic analyses of liver function (29) and its different forms represent different phosphoforms 262 
(29, 30, 31). PDIA3 phosphoform changes occur during sperm capacitation (31), in hyperoxic lung epithelial cells 263 
(30) and in rat livers after fasting or leptin administration (29). Our results suggest that the phosphorylation status 264 
of PDIA3 is affected in fetal human livers by maternal smoking. Interestingly, hyperoxia in lung epithelial cells and 265 
fasting or leptin administration in the rat liver primarily alters the spot volume of the second most-acidic PDIA3 266 
phosphoform, which may modulate signal transducer and activator of transcription 3 (STAT3) signaling (29, 30, 267 
32). This probably corresponds to the same phosphoform increased in male fetal livers in our analysis (Fig. 3Aiii). 268 
ERP29 is another, widely-distributed, endoplasmic reticulum protein involved in processing secreted proteins. 269 
Isoelectric focusing resolves ERP29 to a major spot and several more acidic forms, likely the result of selective 270 
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deamidations (33). Our results show that both native and deamidated forms were altered in response to maternal 271 
smoking. Taken together with the change in PDIA3 phosphoforms, maternal smoking clearly has the potential, via 272 
modifying protein components of the endoplasmic reticulum, to affect the processing and probably functionality 273 
and half-lives of fetal liver secreted proteins. In support of the latter, cigarette smoke disrupts endoplasmic 274 
reticulum components, increases protein disulphide isomerase activity and the formation of aberrant multi-protein 275 
complexes in mice (24) and is associated with elevated protein secretory responses in humans (25). 276 
 277 
AFP, a major plasma protein secreted by the fetal liver, binds fatty acids (34) and modulates estrogenic responses 278 
(35). In adults increased serum AFP levels are associated with liver cirrhosis, hepatic carcinomas or non-279 
seminomatous germ cell tumors (36). Here the reduction in a single AFP spot volume in female fetuses in response 280 
to maternal smoking (Fig. 3Biii) may be the result of altered ERP29, which is also dysregulated in females.  281 
 282 
Stress responses in the human fetal liver  283 
 284 
Consistent with previous measurements of human fetal liver transcripts (1, 2), the expression of fetal liver proteins 285 
involved in stress responses and detoxification was altered in response to maternal smoking, including the 286 
ubiquitous molecular chaperone HSP90AA1 (up-regulated in female smoke-exposed livers; Fig. 2C). Since 287 
HSP90AA1 is essential for the function of the xenotoxicant sensor, Aryl Hydrocarbon Receptor (AHR) (37), 288 
increased HSP90AA1 levels in female smoke-exposed livers may reflect increased AHR levels and/or signaling, 289 
via elevated smoking-delivered polycyclic aromatic hydrocarbon levels in female fetuses (19). Levels of CAT 290 
(which inactivates reactive oxygen species) were also increased in smoke-exposed females, possibly counteracting 291 
the catalase-inhibiting activity of tobacco smoke (38), and/or the increase of by-product reactive oxygen species 292 
from tobacco smoke by Phase I enzymes (39). In male fetal livers maternal smoking was associated with changes 293 
in the volume of a single spot identified as HSBP1 (Fig. 3D). HSBP1 resolves to several isoforms of similar MW 294 
but different pI, corresponding to native (basic) and phosphorylated protein (more acidic) forms (40). Consistent 295 
with the increased phosphorylation and shift in pI of HSBP1 in response to stressors (40), the phosphorylated 296 
HSBP1 (more acidic) form was up-regulated in smoke-exposed male fetuses (Fig. 3Diii). ALDH7A1 plays a role in 297 
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detoxification by reducing aldehydes (41) and both ALDH7A1 protein and transcript levels fell in females but 298 
increased in males (Fig. 2B). Such sex-specific responses in stress- and detoxification- related protein expression 299 
reported here have also been observed in zebrafish livers in response to xenotoxicants (42). 300 
 301 
Sex-specific pathway alterations in the fetal liver 302 
 303 
Even though maternal smoking affected pathways relating to cancer in both sexes, there were sex-differences in the 304 
pathways involved (Table 2). Cellular homeostasis, inflammation and proliferation/apoptosis pathways are linked 305 
to liver fibrosis and cirrhosis (43) and were preferentially affected in male livers. In contrast, the glucose 306 
metabolism disorder pathway, which is also linked to cirrhosis (44), was preferentially affected in females. This 307 
finding is supported by animal studies where exposure of male and female mice in utero to tobacco smoke can 308 
contribute to liver fibrosis in adulthood (45) suggesting that while different pathways may be affected by maternal 309 
smoking, there can be a convergence in disease outcomes later in life. Sexually dimorphic responses can manifest 310 
in other types of stress including differential rodent liver responses to chronic hydrocarbon exposure (46) as well as 311 
high fat diet-reduced insulin sensitivity (47). Sex-specific gene expression differences in the human fetal liver (2), 312 
as well as other organs including the placenta (48) underline that it is not surprising to find sexually dimorphic 313 
responses to stress. Our findings are, therefore, in line with similar studies demonstrating sex-specific responses. 314 
This suggests that sex-specific ameliorative and/or preventive treatments might be applicable for diseases 315 
developing in in utero smoke-exposed individuals.  316 
 317 
Overall, in this study we have shown that maternal smoking disrupts diverse pathways in the fetal liver which 318 
suggests that for a set of childhood and/or adulthood diseases commonly linked to maternal smoking, disruption of 319 
fetal liver physiology may be one of the bridges connecting developmental perturbations to disease later in life. Our 320 
proteomic screen and IPA analysis has also highlighted the sex-specific manner in which fetal livers are affected by 321 
maternal smoking suggesting that males and females may be predisposed to different diseases as a result of smoke 322 
exposure.  323 
 324 
325 
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FIGURE LEGENDS 497 
 498 
Figure 1: Summary of altered spot analysis, group distribution and spot position on 2D-PAGE. The 499 
distribution of spots altered by maternal smoking (blue circle), by sex irrespective of maternal smoking (pink 500 
circle) and of those whose sex-differences were affected by maternal smoking (yellow circle) are shown in the 501 
Venn diagram.  502 
 503 
Figure 2: Comparison between spot volume differences and transcript levels of identified proteins. Panels (A-504 
D) show (i) spot volume and (ii) transcript of all data points with means represented by a green line. Significant 505 
differences (One-way ANOVA or Wilcoxon test) between groups are indicated by letters in the boxes above each 506 
graph. Within each spot volume (i) or transcript (ii), groups that do not share a letter are significantly (P < 0.05) 507 
different, i.e. where the superscript letters are shared between groups, there is not statistically significant difference. 508 
“C”: control; “SE” smoke exposed. 509 
 510 
Figure 3: Comparison between spot volume differences and total protein levels of identified proteins. Panels 511 
(A-D) show (i) spot volume, (ii) protein levels with means represented by a green line and (ii) representative 1D 512 
(each lane corresponding to a protein extract from each of the four groups) and 2D Western blots. Significant 513 
differences (One-way ANOVA or Wilcoxon test) between groups are indicated by letters in the boxes above each 514 
graph. Groups that do not share a letter are significantly (P < 0.05) different, i.e. where the superscript letters are 515 
shared between groups, there is not statistically significant difference. Black arrowheads in (iii) indicate the protein 516 
band in question (1D) and the spot whose volume was altered (2D). X-ed arrowheads represent bands from 517 
immunoblotting of the membrane with other antibodies. “C”: Control; “SE” smoke exposed. 518 
 519 
Table 1: Protein candidates from LC-MS/MS spot analysis. Spot numbers with an asterisk indicate detection of 
a single candidate. Only fold-changes that achieved significance (p<0.05) are shown. ISD, induction of sex-
difference; RSD, reversal of sex-difference; ASD, abolishment of sex-difference.  
 
 
Spot # Gene 
symbol  
Protein Name 
 
Fold Change by 
Maternal Smoking 
Fold Change by 
Sex in Controls 
Smoke effect on Sex 
Differences (fold change) 
743 USP5 Ubiquitin carboxyl-terminal 
hydrolase 5 
 
+1.22 (♀) No No 
 
HSP90AA1 Heat shock protein 90 isoform 2 
 
990 AFP Alpha fetoprotein 
 
-1.31 (♀) +1.15 (♀) RSD;+1.20 (♂) 
1006 SDHA Succinate dehydrogenase 
 
-1.23 (♀) +1.26 (♀) No 
1090 * CCT6A T-complex protein 1 subunit zeta 
isoform a 
 
No +1.15 (♂) No 
1123 CAT Catalase 
 
+1.14 (♀) No IDS;+1.13 (♀) 
1129 GLUD1 Glutamate dehydrogenase 1, 
mitochondrial precursor 
 
+1.18 (f) No IDS;+1.23 (♀) 
CAT Catalase 
 
1149 PDIA3 Protein disulphide isomerase A3 
 
+1.21(♂) No IDS;+1.21 (♂) 
1150 * SERPINA1 alpha-1-antitrypsin precursor 
 
+1.23 (♂) No IDS;+1.28 (♂) 
1172 CALR Calreticulin precursor 
 
+1.30 (♀) No IDS;+1.14 (♀) 
1190 KRT8 Keratin type II Cytoskeletal 8 
isoform 2 
 
+1.30(♀) No IDS;+1.16 (♀) 
1205 KRT8 Keratin type II Cytoskeletal 8 
isoform 2 
 
+1.13 (♂) No IDS;+1.24 (♂) 
1221 * ALDH7A1 alpha-aminoadipic semialdehyde 
dehydrogenase isoform 2 
 
-1.22 (♀); +1.24(♂) +1.27 (♀) RDS;+1.26 (♂) 
1328 PGK1 Phosphoglycerate kinase 1 
 
+1.27 (♀) No IDS;+1.40 (♀) 
1501 * CRYL1 Lambda crystallin homolog 
 
+1.25 (♀) +1.16 (♂) No 
1589 ECHS1 Enoyl Coenzyme Hydratase 1 
 
+1.28 (♀) -1.33(♂) No IDS; +1.42 (♀) 
1591 PNP Purine nucleoside phosphorylase 
 
+1.24 (m)  No IDS;+1.13 (♂) 
1645 EEF1B2 Elongation factor 1 beta 
 
+1.20 (♂) No IDS;+1.16 (♂) 
YWHAE 14-3-3 protein epsilon 
 
1673 ERp29 Endoplasmic reticulum resident 
protein 29 isoform 1 precursor 
 
No No IDS;+1.13 (♀) 
1678 ERp29 Endoplasmic reticulum resident 
protein 29 isoform 1 precursor 
 
+1.16 (♀); -1.18(♂) +1.13 (♂) RDS;+1.18 (♀) 
 
TPI1 Triose phosphate isomerase 
isoform 1 
 
1679 HSPB1 Heat shock protein beta 1 
 
+1.18 (♂) No No 
1684 ERp29 Endoplasmic reticulum resident 
protein 29 isoform 1 precursor 
 
+1.14 (♀) No IDS;+1.16 (♀) 
1786 SPRYD4 SPRY domain-containing protein 4 
 
+1.35 (♂) No IDS;+1.22 (♂) 
FLT1 Ferritin Light Chain 
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 1 
Table 2: Pathways affected in the human fetal liver by maternal smoking. Disease pathways formatted in 1 
bold were dysregulated in both sexes. Diseases Pathways are presented by descending P-value. 2 
 3 
Diseases  Molecules P-value 
M
a
le
s 
abdominal cancer ALDH7A1, ECHS1, EEF1B2, FLT1, HSPB1, KRT8, PDIA3, 
PNP, TPI1 
3.29E-02 
apoptosis FLT1, HSPB1, KRT8, PDIA3, PNP 2.13E-02 
cellular homeostasis FLT1, HSPB1, KRT8, PNP 1.38E-02 
genital tract cancer ALDH7A1, EEF1B2, FLT1, HSPB1, KRT8, PDIA3 1.55E-02 
inflammation of organ FLT1, KRT8, PDIA3, TPI1 5.44E-04 
lung cancer EEF1B2, FLT1, KRT8, TPI1 2.00E-03 
malignant neoplasm of 
pelvis 
ECHS1, EEF1B2, FLT1, HSPB1, KRT8, PDIA3 1.18E-02 
necrosis FLT1, HSPB1, KRT8, PDIA3, PNP 
EEF1B2, FLT1, HSPB1, KRT8, PDIA3, PNP 
1.94E-02 
pelvic cancer 2.35E-02 
proliferation of cells EEF1B2, FLT1, HSPB1, KRT8, PDIA3, PNP 1.94E-02 
quantity of cells FLT1,HSPB1,KRT8,PNP 1.73E-02 
F
em
a
le
s 
 
abdominal cancer 
 
AFP, ALDH7A1, CAT, CRYL1, ECHS1, GLUD1, 
HSP90AA1, KRT8, PGK1, SDHA, TPI1, USP5 
 
7.88E-03 
breast and colorectal 
cancer 
AFP, CAT, CRYL1, ECHS1, HSP90AA1, KRT8, PGK1, TPI1 3.38E-02 
digestive tract cancer AFP, ALDH7A1, CAT, CRYL1, ECHS1, GLUD1, 
HSP90AA1, KRT8, PGK1, SDHA, TPI1 
8.67E-03 
epithelial cancer AFP, ALDH7A1, CAT, ECHS1, GLUD1, HSP90AA1, KRT8, 
PGK1, SDHA, TPI1, USP5 
4.16E-02 
genital tract cancer AFP, ALDH7A1, HSP90AA1, KRT8, PGK1, SDHA, USP5 1.87E-02 
glucose metabolism 
disorder 
CAT, ECHS1,GLUD1, KRT8 1.74E-02 
metastasis AFP, CAT, HSP90AA1, KRT8 2.27E-03 
necrosis AFP, CAT, GLUD1, HSP90AA1, KRT8, SDHA 1.64E-02 
proliferation of tumor 
cell lines 
AFP, CAT, HSP90AA1, KRT8 3.07E-02 
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